A PHASE 1 PILOT STUDY OF ULTRA-LOW DOSE IL-2 AS GVHD PROPHYLAXIS IN HAPLO-IDENTICAL STEM CELL TRANSPLANTATION

EHA Library, Sawa Ito, 215181

THE IMPACT OF CMV REACTIVATION ON HSCT OUTCOMES IN CHILDREN WITH MALIGNANCIES: A 13 YEARS SINGLE CENTER EXPERIENCE

EHA Library, Maria Cristina Menconi, 215182

A REAL-LIFE SINGLE CENTER RETROSPECTIVE ANALYSIS TO EVALUATE EBMT RISK INDEX AS A PROGNOSTIC FACTOR IN PEDIATRIC HSCT

EHA Library, Maria Cristina Menconi, 215183

THE EXPERIENCE OF USING DEFIBROTIDE FOR THE PREVENTION AND TREATMENT OF HEPATIC VENO-OCCLUSIVE DISEASE AFTER PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; A SINGLE CENTER EXPERIENCE

EHA Library, Bulent Antmen, 215184

THE HEMATOPOIETIC CELL TRANSPLANTATION COMORBIDITY INDEX IN THE CONTEXT OF AUTOLOGOUS STEM CELL TRANSPLANTATION CAN PREDICTS CLINICAL OUTCOMES.

EHA Library, Alexandra Martínez Roca, 215185

INTRA-BONE CORD BLOOD TRANSPLANT WITHOUT IN-VIVO T-CELL DEPLETION: RESULTS IN 12 PATIENTS.

EHA Library, Elisabetta Xue, 215186

HEMATOPOIETIC REGENERATION AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION WITH ACTUAL BODY WEIGHT BASED DOSING OF CONDITIONING CHEMOTHERAPY

EHA Library, David Fuchs, 215187

IMPACT OF MIXED CHIMERISM IN T REGULATORY CELLS ON RELAPSE RATE IN ACUTE LEUKEMIA PATIENTS AFTER ALLO-HSCT

EHA Library, Mikhail Drokov, 215188

REDUCED-INTENSITY CONDITIONING WITH FLUDARABINE AND BUSULFAN VERSUS FLUDARABINE AND MELPHALAN FOR T DEPLETED ALLOGENEIC TRANSPLANT IN MYELOID MALIGNANCIES: AN EXPERIENCE OF A TERTIARY CENTRE

EHA Library, MARTA LOPES, 215189

THYMIC FUNCTION AFTER HAPLOIDENTICAL ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION.

EHA Library, Benedetto Bruno, 215190

A MESENCHYMAL STROMAL CELL (MSC)-DERIVED COMBINATION OF CXCL5 AND ANTI-CCL24 IS SYNERGISTIC AND SUPERIOR TO MSC AND CYCLOSPORINE FOR THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE

EHA Library, Zhi Yong, 215191

GENERATION OF IMMORTAL MURINE HEMATOPOIETIC STEM/PROGENITOR AND LEUKEMIC STEM CELL LINES FROM TRANSGENIC MICE

EHA Library, Eszter Doma, 215192

GENOME WIDE METHYLATION IN HEMATOPOIETIC STEM CELLS AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION

EHA Library, Stefania Trino, 215193

TYPE-I-INTERFERON INDUCING MICROBIAL METABOLITES PROTECT FROM INFLAMMATORY TISSUE DAMAGE

EHA Library, Hendrik Poeck, 215194

EX-VIVO GENERATED HUMAN CORD BLOOD MYELOID-DERIVED SUPPRESSOR CELLS (HCB-MDSCS) ATTENUATE MURINE CHRONIC GRAFT-VERSUS-HOST DISEASES

EHA Library, Chang-Ki Min, 215195

EFFICACY OF DEFIBROTIDE FOR PREVENTION AND TREATMENT OF ACUTE GRAFT-VERSUS HOST DISEASE IN A FULLY MHC-MISMATCHED MURINE MODEL OF ALLOGENEIC BONE MARROW TRANSPLANTATION

EHA Library, David García-Bernal, 215196

CONSTRUCTION OF A GFP KNOCK-IN CELL LINE FOR STUDYING GAMMA-GLOBIN CIS-ACTING ELEMENTS

EHA Library, Mehdi Banan, 215198

LONG-TERM LONGITUDINAL PROSPECTIVE CMR STUDY IN PATIENTS WITH THALASSEMIA MAJOR

EHA Library, Alessia Pepe, 215199

CEREBROVASCULAR DISEASE IN BETA-THALASSEMIA: NOT A DISEASE RELATED COMPLICATION?

EHA Library, Immacolata Tartaglione, 215200

CO-INHERITANCE OF SOUTHEAST ASIAN OVALOCYTOSIS WITH Β-THALASSEMIA OR HEMOGLOBIN E HETEROZYGOTE LEAD TO ANEMIA IN CHILDREN

EHA Library, Pallapa Banjerdlak, 215201

DAILY ALTERNATING DEFERASIROX AND DEFERIPRONE AS NEW THERAPEUTIC SCHEME FOR IRON OVERLOAD IN UNTREATABLE TRANSFUSION DIPENDENT THALASSEMIA PATIENTS

EHA Library, Valeria Pinto, 215202

DENOSUMAB EFFECTS ON SERUM LEVELS OF THE BONE MORPHOGENIC PROTEINS ANTAGONIST NOGGIN IN PATIENTS WITH BETA-THALASSEMIA MAJOR AND OSTEOPOROSIS

EHA Library, Evangelos Terpos, 215203

FERRITN LEVELS BELOW 500 NG/ML IN TRANSFUSION DEPENDENT THALASSEMIA PATIENTS: HOW TO MODULATE CHELATION TREATMENT?

EHA Library, Natalia scaramellini, 215204

COMPARAISON OF MORBIDITIES BETWEEN NON TRANSFUSION AND TRANSFUSION DEPENDENT THALASSEMIA PATIENTS OLDER THAN 45 YEARS

EHA Library, Alessia Marcon, 215205

A RANDOMIZED, CONTROLLED, PHASE III STUDY TO EVALUATE S-303/GLUTATHIONE PATHOGEN-INACTIVATED RED BLOOD CELLS IN THALASSEMIA MAJOR PATIENTS (SPARC)

EHA Library, Yesim Aydinok, 215206

EVALUATION OF VASCULAR HEALTH OF E-BETA THALASSEMIA PATIENTS: EFFECT OF IRON OVERLOAD

EHA Library, DIBYENDU DE, 215207

CHRONIC HEPATITIS C VIRUS INFECTION IN THALASSEMIA MAJOR: A NEW CARDIOVASCULAR RISK FACTOR?

EHA Library, Alessia Pepe, 215208

PHENOTYPIC HETEROGENEITY OF HAEMOGLOBIN E BETA THALASSEMIA AND ITS DETERMINANTS- IT’S NOT ONLY HAEMOGLOBIN F!

EHA Library, Siddhesh Kalantri, 215209

EFFICACY AND SAFETY OF RESVERATROL, AN ORAL HBF AUGMENTING AGENT, IN PATIENTS WITH BETA THALASSEMIA INTERMEDIA

EHA Library, Mehran Karimi, 215210

HYPERURICEMIA, URINE URIC EXCRETION AND ITS COMPLICATIONS IN THALASSEMIA PATIENTS

EHA Library, Adisak Tantiworawit, 215211

THE VALUE OF MAGNESIUM LEVELS IN THE HAEMOSTASIS OF PATIENTS WITH Β-THALASSAEMIA.

EHA Library, Nargiz Aliyeva, 215212

ASYMPTOMATIC MALARIA IN CASES OF HBE BETA THALASSEMIA: A PILOT STUDY FROM EASTERN INDIA.

EHA Library, Siddhesh Kalantri, 215213

CHARACTERISTICS OF PLATELET COUNT AND SIZE AND DIAGNOSTIC ACCURACY OF MEAN PLATELET VOLUME IN PATIENTS WITH VENOUS THROMBOEMBOLISM. A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Farzaneh Sadeghi, 215214

SEASONAL VARIATION IN PULMONARY EMBOLISM BUT NOT DEEP VEIN THROMBOSIS INCIDENCE: A KOREAN NATIONWIDE VENOUS THROMBOEMBOLISM EPIDEMIOLOGY STUDY

EHA Library, Junshik Hong, 215215

BLEEDING AND THROMBOTIC EVENTS RELATED TO PERIOPERATIVE CESSATION OF DIRECT ORAL ANTICOAGULANTS

EHA Library, Stephanie Lam, 215216

TROMBOSIS IN LYMPHOMA, INCIDENCE, RISK FACTORS AND MANAGEMENT.

EHA Library, Virginia Pradillo, 215217

PLATELET HYPERREACTIVITY AND POSTOPERATIVE VENOUS THROMBOEMBOLISM IN KNEE REPLACEMENT ARTHROPLASTY

EHA Library, jimyung Kim, 215218

THROMBOEMBOLISM IN CHILDREN WITH CANCER; A RETROSPECTIVE MULTICENTER STUDY IN KOREA

EHA Library, Hyoung Soo Choi, 215219

A RETROSPECTIVE ANALYSIS OF UTILISATION OF DIRECT ORAL ANTICOAGULANT LEVELS FROM A TERTIARY HAEMATOLOGY CENTRE

EHA Library, Nicholas Denny, 215220

LONG- TERM MANAGEMENT OF RECURRENT VENOUS THROMBOEMBOLISM IN BLOOD CANCER PATIENTS AT HIGH BLEEDING RISK.

EHA Library, Mariasanta Napolitano, 215221

A MULTICENTER EXPERIENCE WITH IDARUCIZUMAB “IN REAL WORLD” AS REVERSAL ANTICOAGULATION OF DABIGATRÁN

EHA Library, Isabel Izquierdo García, 215222

THE ASSOCIATION BETWEEN APTT-BASED CLOT WAVEFORM ANALYSIS AND ACUTE VENOUS THROMBOEMBOLISM

EHA Library, Ian Wu, 215223

A TERTIARY INSTITUTION BLOOD BANK EXPERIENCE AFTER THE IMPLEMENTATION OF A UNIFIED NATIONAL MASSIVE TRANSFUSION PROTOCOL (MTP) IN SINGAPORE.

EHA Library, Chun Tsu Lee, 215224

DURATION OF RED BLOOD CELL STORAGE IS SIGNIFICANTLY ASSOCIATED WITH HEMOGLOBIN INCREASE AFTER BLOOD TRANSFUSION

EHA Library, Jenny Rydén, 215225

RED CELL TRANSFUSION THRESHOLDS IN PATIENTS RECEIVING INDUCTION CHEMOTHERAPY FOR ACUTE MYELOID LEUKEMIA

EHA Library, Amy Trottier, 215226

DEVELOPMENT OF HUMANIZED MOUSE MODELS TO EVALUATE AND PREVENT MOTHER-TO-CHILD HTLV-1 TRANSMISSIONS

EHA Library, Takuo Mizukami, 215227

A DESCRIPTIVE STUDY OF TRANSFUSION-RELATED ACUTE LUNG INJURY (TRALI) IN THE CANARY ISLANDS.

EHA Library, Cynthia ACOSTA FLEITAS, 215228

DYE-LIGANDS AFFINITY CHROMATOGRAPHY IN PROCESS OF FACTOR VIII PURIFICATION

EHA Library, Nataliya Shurko, 215229

TEN YEAR EXPERIENCE OF RED BLOOD CELL TRANSFUSION ADEQUACY INDEX AS PART OF PATIENT BLOOD MANAGEMENT PROGRAM.

EHA Library, GUSTAVO DuARTE, 215230

A 3-PART DIFF POCT CELL ANALYZER AT THE HEMATO-ONCOLOGY WARD FOR CLINICAL DECISION MAKING OF PLATELET TRANSFUSION AND CHEMOTHERAPY

EHA Library, Nele Van den Eede, 215231

EVALUATION OF OXYGEN TRANSPORT OF BLOOD IN PATIENTS WITH ANEMIA ON THE BACKGROUND OF THE RED BLOOD CELLS TRANSFUSIONS

EHA Library, Nikolay Romanenko, 215232

SENSITIVITY TO VENETOCLAX IN BCP-ALL IS CLOSELY CORRELATED TO HIGH FUNCTIONAL BCL-2 DEPENDENCE AND CAN BE ENHANCED BY DEPLETION OF MCL-1

EHA Library, Felix Seyfried, 215828

A NEW HUMANIZED MONOCLONAL ANTIBODY AGAINST A SPECIFIC GLYCOSYLATED EPITOPE OF CD43 ANTIGEN FOR THE THERAPEUTIC TARGETING OF ACUTE LYMPHOBLASTIC LEUKEMIA T (T-ALL)

EHA Library, CIRINO BOTTA, 215829

CD123 X CD3 BISPECIFIC DART® MOLECULE EFFICIENTLY ACTIVATES T CELLS TO KILL PRIMARY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA CELLS

EHA Library, Dragana Slavkovic Lukic, 215830

POTENT PRECLINICAL ACTIVITIES OF CD9 ANTIBODIES AGAINST HIGH-RISK PEDIATRIC B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Kam Tong Leung, 215831

PRECLINICAL DEMONSTRATION OF INTRACELLULAR ACTIVITY OF ASPARAGINASE ENCAPSULATED IN RED BLOOD CELLS BOTH IN THE ABSENCE AND IN THE PRESENCE OF NEUTRALIZING ANTI-ASPARAGINASE ANTIBODIES

EHA Library, Karine Aguera, 215832

TARGETING G9A/EHMT2 IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Anna Montanaro, 215833

LEUKAEMIC BLASTS OUTSOURCE MITOPHAGY TO THEIR MICROENVIRONMENT

EHA Library, Rebecca Horton, 215834

THERAPEUTIC TARGETING OF THE LEUKAEMIC FUSION GENE RUNX1/ETO VIA RNAI

EHA Library, Hasan Issa, 215835

PREVALENCE AND CLINICAL IMPLICATIONS OF PPM1D TRUNCATING MUTATIONS IN THERAPY-RELATED MYELOID NEOPLASMS

EHA Library, Joanne Hsu, 215836

LONGITUDINAL GENOMIC AND TRANSCRIPTOMIC TRACKING OF CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA

EHA Library, Taehyung Kim, 215837

IMPACT OF COMORBIDITY ON DISEASE CHARACTERISTICS, TREATMENT INTENT AND OUTCOME IN DIFFUSE LARGE B-CELL LYMPHOMA – A SWEDISH LYMPHOMA REGISTER STUDY

EHA Library, Tove Wästerlid, 215838

OVERWEIGHT LYMPHOMA PATIENTS TREATED BY ACTUAL BODY WEIGHT HAD NO EXCESS OF CHEMOTHERAPY TOXICITY: EXPERIENCE FROM TWO LARGE TRIALS

EHA Library, Bridgin Merron, 215839

DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) PRESENTING WITH SYNCRHONOUS CNS AND SYSTEMIC DISEASE AT DIAGNOSIS: RESULTS FROM AN INTERNATIONAL COLLABORATIVE STUDY

EHA Library, Joel Wight, 215840

PRECLINICAL VALIDATION OF VECABRUTINIB (SNS-062) EFFICIENCY AGAINST BTK-C481S MUTATED LYMPHOMAS

EHA Library, Camille Libre, 215841

IDENTIFICATION OF NOVEL MECHANISMS UNDERLYING FUNCTIONAL RESPONSE TO DRUG-INDUCED READTHROUGH OF HAEMOPHILIA B NONSENSE MUTATIONS

EHA Library, Mattia Ferrarese, 215842

APPLICATION OF THE ISTH BLEEDING SCORE IN HEMOPHILIA

EHA Library, NAVEENA FATIMA, 215844

LOW PROPORTION OF MYELOID DERIVED SUPPRESSOR CELL POPULATIONS IN THE PERIPHERAL BLOOD OF PATIENTS WITH CHRONIC IDIOPATHIC NEUTROPENIA

EHA Library, Nikoleta Bizymi, 215845

CLINICAL SIGNIFICANCE OF PNH CLONES IN 3085 PATIENTS WITH CYTOPENIA: A LARGE SINGLE-CENTER EXPERIENCE.

EHA Library, Bruno Fattizzo, 215846

USP28 LOCALIZED IN 11Q23 REGULATES C-MYC, NOTCH1 AND FBXW7 IN CLL

EHA Library, Viola Meyer-Pannwitt, 215847

DYNAMIC REGULATION OF THE HS1/CXCR4 AXIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA CELLS

EHA Library, Luca Pavesi, 215848

EPIGENETIC DRUG SCREEN ON RITUXIMAB-RESISTANT CELLS REVEALED AN UNEXPECTED ROLE OF AURORA KINASE INHIBITORS IN CD20 EXPRESSION

EHA Library, Veronika Kozlova, 215849

B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN CLL PATIENTS TREATED WITH LENALIDOMIDE

EHA Library, Moritz Fürstenau, 215850

IMPLEMENTATION OF THE DIAGNOSTIC WORKFLOW OF HEREDITARY ANEMIAS BY USING TARGETED-NGS PANEL ANALYSIS

EHA Library, Roberta Russo, 215851

CONGENITAL ERYTHROPOIETIC PORPHYRIA AS A MIMICKER OF CHRONIC HEMOLYTIC ANEMIAS IN INFANTS

EHA Library, Yasmine El Chazli, 215852

DUAL TARGETING STRATEGY OF ACUTE MYELOID LEUKEMIA BY ENGINEERED CYTOKINE-INDUCED KILLER CELLS COEXPRESSING AN INTERLEUKIN 3 CHIMERIC ANTIGEN RECEPTOR (CAR) AND AN ANTI-CD33 COSTIMULATORY RECEPTOR

EHA Library, Vincenzo Perriello, 215853

SYNERGISTIC T CELL SIGNALING BY CD79A/CD40 COSTIMULATORY ENDODOMAIN ENHANCES CD19 CHIMERIC ANTIGEN RECEPTOR T CELL PROLIFERATION AND SURVIVAL

EHA Library, Jakrawadee Julamanee, 215854

RNAI-MEDIATED SILENCING OF ENDOGENOUS TCR ENHANCES TUMOR KILLING ACTIVITY OF TCR-ENGINEERED WT1-SPECIFIC T CELLS

EHA Library, Diana Campillo, 215855

THE STUDY OF LYMPHOCYTES SUBPOPULATIONS IN PERIPHERAL BLOOD OF PATIENTS WITH AND WITHOUT GVHD PROPHYLAXIS BY MEANS OF MULTIPOTENT MESENCHYMAL STROMAL CELLS AFTER ALLOGENEIC BMT

EHA Library, Yulia Davydova, 215856

NORADRENALINE STIMULATES MITOCHONDRIAL REALLOCATION AND HAEMATOPOIETIC MIGRATION TO THE SPLEEN

EHA Library, Adam Morfakis, 215857

AGE-RELATED CLONAL HEMATOPOIESIS (ARCH) IN CENTENARIANS AND CARDIOVASCULAR DISEASE PATIENTS: A SURVIVAL BIAS HYPOTHESIS

EHA Library, Luca Bertamini, 215858

THE IN VIVO EFFECT OF CHEMOTHERAPY AND CXCR4 ANTAGONISM ON AML AND T-ALL CELL MIGRATION IN THE BONE MARROW.

EHA Library, Delfim Duarte, 215859

CD83 IS A NEW POTENTIAL BIOMARKER AND THERAPEUTIC TARGET FOR HODGKIN LYMPHOMA

EHA Library, Ziduo Li, 215860

AUTOLOGOUS STEM CELL TRANSPLANTATION MAY CURE FOLLICULAR LYMPHOMA PATIENTS WITH EARLY THERAPY FAILURE WHO REACH COMPLETE RESPONSE AFTER RESCUE TREATMENT IRRESPECTIVE OF PREVIOUS RITUXIAMB EXPOSURE.

EHA Library, Ana Jiménez Ubieto, 215861

IRON OVERLOAD IN RARE HEREDITARY HEMOLYTIC ANEMIA

EHA Library, Stephanie van Straaten, 215862

TISSUE IRON OVERLOAD ASSESSMENT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Kira Lukina, 215863

SOMATIC MUTATIONS AS MARKERS OF OUTCOME AFTER AZACITIDINE TREATMENT FOLLOWED BY ALLOGENEIC STEM CELL TRANSPLANTION (HSCT) IN HIGHER-RISK (HR) MDS AND LOW-BLAST COUNT ACUTE MYELOID LEUKEMIA (LBC-AML)

EHA Library, Giulia Falconi, 215864

PROGNOSTIC IMPACT OF ASXL1 MUTATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND MULTILINEAGE DYSPLASIA WITH OR WITHOUT RING SIDEROBLASTS.

EHA Library, Abhishek Mangaonkar, 215865

CLINICAL OUTCOMES OF PATIENTS WITH MDS/MPN OVERLAP SYNDROMES

EHA Library, Caroline MCNAMARA, 215866

THE EVALUATION OF OXIDATIVE STRESS AND IRON METABOLISM MARKERS IN MYELODYSPLASTIC SYNDROMES

EHA Library, Mihnea-Alexandru Găman, 215867

EXPRESSION OF P53 ISOFORMS AT MRNA LEVEL IN MULTIPLE MYELOMA: IMPLICATIONS FOR CLINICAL OUTCOME

EHA Library, Elizabeta A. Rojas, 215868

ADAR1-MEDIATED-A-TO-I-EDITING IS BIOLOGICALLY AND CLINICALLY RELEVANT IN MULTIPLE MYELOMA

EHA Library, Phaik Ju Teoh, 215869

PEPTIDE STIMULATION OF PD-L1 SPECIFIC T CELLS NATURALLY OCCURING IN MYELOMA PATIENTS AUGMENT THE ADCC ACTIVITY OF DARATUMUMAB

EHA Library, Nicolai Jørgensen, 215870

NOVEL KINASE INHIBITORS AFURESERTIB AND PIM447 ARE ACTIVE IN A PREDICTIVE MYELOMA IN VIVO MODEL, AND A CRISPR GENOME-WIDE SCREENING APPROACH IDENTIFIES BIOMARKERS DETERMINING SUSCEPTIBILITY

EHA Library, Niamh Keane, 215871

GENOMIC CHARACTERIZATION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS IN MULTIPLE MYELOMA REVEALS DISTINCT PATTERNS OF DISEASE EVOLUTION

EHA Library, Aino-Maija Leppä, 215872

PROGNOSTIC SIGNIFICANCE OF MAGNETIC RESONANCE IMAGING BEFORE AND AFTER UPFRONT AUTOLOGOUS TRANSPLANTATION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA – A SUBGROUP ANALYSIS FROM THE GMMG MM5 PHASE III TRIAL

EHA Library, Maximilian Merz, 215873

ANTI-SLAMF7 ANTIBODY SUPPRESSES FIBROCYTE DIFFERENTIATION AS A POTENT THERAPEUTIC AGENT FOR MYELOFIBROSIS

EHA Library, Takaaki Maekawa, 215874

HETEROZYGOUS CONSTITUTIVE CALR DEL52 KNOCK-IN MICE SHOW A TRANSPLANTABLE ET-PHENOTYPE WHILE THE HOMOZYGOUS STATE IS LETHAL DUE TO A HEART DEFECT

EHA Library, Thomas Balligand, 215875

PATIENT-DERIVED INDUCED PLURIPOTENT STEM CELLS REVEALED CALCIUM/CALMODULIN DEPENDENT PROTEIN KINASE 2 AS A POTENTIAL THERAPEUTIC TARGET OF MYELOFIBROSIS

EHA Library, Masashi Miyauchi, 215876

DEVELOPMENT OF A PROGNOSTICALLY RELEVANT ‘CACHEXIA INDEX’ IN PRIMARY MYELOFIBROSIS USING SERUM ALBUMIN AND CHOLESTEROL LEVELS

EHA Library, maura nicolosi, 215877